Ignite Creation Date:
2024-05-06 @ 8:15 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06302140
Status:
RECRUITING
Last Update Posted:
2024-03-29
First Post:
2024-02-23
Brief Title:
A Mass Balance Study of 14C-Nanatinostat and Relative Bioavailability Study of Nanatinostat in Patients With Advanced Cancers
Sponsor:
Viracta Therapeutics Inc
Organization:
Viracta Therapeutics Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Advanced Cancer |
Keywords: